Zollinger-Ellison syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Historical Perspective== | ==Historical Perspective== | ||
*In 1955, Zollinger and Ellison | * In 1955, Zollinger and Ellison announced their concept about ulcerogenic islet cell tumor which caused marked ulcer diathesis due to gastric hyperacidity.<ref name="pmid1746876">{{cite journal| author=Zollinger RM| title=[The history of the Zollinger-Ellison syndrome]. | journal=Ann Gastroenterol Hepatol (Paris) | year= 1991 | volume= 27 | issue= 5 | pages= 223-6 | pmid=1746876 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1746876 }} </ref> | ||
* Dr. Robert M. Zollinger and Dr. Edwin H. Ellison announced their theory at annual meeting of the American Surgical Association in Philadelphia in April 1956.<ref name="pmid13259432">{{cite journal| author=ZOLLINGER RM, ELLISON EH| title=Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. | journal=Ann Surg | year= 1955 | volume= 142 | issue= 4 | pages= 709-23; discussion, 724-8 | pmid=13259432 | doi= | pmc=1465210 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13259432 }} </ref> | |||
* This concept raised from clinical case of two women who presented with perforated jejunal ulcers accompanied with severe ulcer diathesis. | |||
* In 1960s, gastrin was described as a main pathogenesis of gastric hyperacidity.<ref name="pmid17053435">{{cite journal| author=Hou W, Schubert ML| title=Gastric secretion. | journal=Curr Opin Gastroenterol | year= 2006 | volume= 22 | issue= 6 | pages= 593-8 | pmid=17053435 | doi=10.1097/01.mog.0000245538.43142.87 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17053435 }} </ref> | |||
* | |||
==References== | ==References== | ||
Revision as of 15:04, 15 March 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
|
Zollinger-Ellison syndrome Microchapters |
|
Differentiating Zollinger-Ellison syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Zollinger-Ellison syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Zollinger-Ellison syndrome historical perspective |
|
Zollinger-Ellison syndrome historical perspective in the news |
|
Risk calculators and risk factors for Zollinger-Ellison syndrome historical perspective |
Overview
In 1955, Zollinger and Ellison published their seminal paper on gastrinomas wherein the Zollinger-Ellison syndrome was first discussed.
Historical Perspective
- In 1955, Zollinger and Ellison announced their concept about ulcerogenic islet cell tumor which caused marked ulcer diathesis due to gastric hyperacidity.[1]
- Dr. Robert M. Zollinger and Dr. Edwin H. Ellison announced their theory at annual meeting of the American Surgical Association in Philadelphia in April 1956.[2]
- This concept raised from clinical case of two women who presented with perforated jejunal ulcers accompanied with severe ulcer diathesis.
- In 1960s, gastrin was described as a main pathogenesis of gastric hyperacidity.[3]
References
- ↑ Zollinger RM (1991). "[The history of the Zollinger-Ellison syndrome]". Ann Gastroenterol Hepatol (Paris). 27 (5): 223–6. PMID 1746876.
- ↑ ZOLLINGER RM, ELLISON EH (1955). "Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas". Ann Surg. 142 (4): 709–23, discussion, 724–8. PMC 1465210. PMID 13259432.
- ↑ Hou W, Schubert ML (2006). "Gastric secretion". Curr Opin Gastroenterol. 22 (6): 593–8. doi:10.1097/01.mog.0000245538.43142.87. PMID 17053435.